BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 26679344)

  • 1. The transcriptional profile of coronary arteritis in Kawasaki disease.
    Rowley AH; Wylie KM; Kim KY; Pink AJ; Yang A; Reindel R; Baker SC; Shulman ST; Orenstein JM; Lingen MW; Weinstock GM; Wylie TN
    BMC Genomics; 2015 Dec; 16():1076. PubMed ID: 26679344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allograft Inflammatory Factor-1 Links T-Cell Activation, Interferon Response, and Macrophage Activation in Chronic Kawasaki Disease Arteritis.
    Rowley AH; Baker SC; Kim KA; Shulman ST; Yang A; Arrollo D; DeBerge M; Han S; Sibinga NES; Pink AJ; Thorp EB
    J Pediatric Infect Dis Soc; 2017 Sep; 6(3):e94-e102. PubMed ID: 28505365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arterial immune protein expression demonstrates the complexity of immune responses in Kawasaki disease arteritis.
    Cameron SA; White SM; Arrollo D; Shulman ST; Rowley AH
    Clin Exp Immunol; 2017 Nov; 190(2):244-250. PubMed ID: 28707750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipidomics links oxidized phosphatidylcholines and coronary arteritis in Kawasaki disease.
    Nakashima Y; Sakai Y; Mizuno Y; Furuno K; Hirono K; Takatsuki S; Suzuki H; Onouchi Y; Kobayashi T; Tanabe K; Hamase K; Miyamoto T; Aoyagi R; Arita M; Yamamura K; Tanaka T; Nishio H; Takada H; Ohga S; Hara T
    Cardiovasc Res; 2021 Jan; 117(1):96-108. PubMed ID: 31782770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease.
    Hu P; Jiang GM; Wu Y; Huang BY; Liu SY; Zhang DD; Xu Y; Wu YF; Xia X; Wei W; Hu B
    Clin Chim Acta; 2017 Aug; 471():76-80. PubMed ID: 28526535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variants of ADAM17 are implicated in the pathological process of Kawasaki disease and secondary coronary artery lesions via the TGF-β/SMAD3 signaling pathway.
    Peng Q; Deng Y; Yang X; Leng X; Yang Y; Liu H
    Eur J Pediatr; 2016 May; 175(5):705-13. PubMed ID: 26833052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcineurin inhibitors exacerbate coronary arteritis via the MyD88 signalling pathway in a murine model of Kawasaki disease.
    Murata K; Motomura Y; Tanaka T; Kanno S; Yano T; Onimaru M; Shimoyama A; Nishio H; Sakai Y; Oh-Hora M; Hara H; Fukase K; Takada H; Masuda S; Ohga S; Yamasaki S; Hara T
    Clin Exp Immunol; 2017 Oct; 190(1):54-67. PubMed ID: 28640392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Kawasaki disease and atherosclerosis].
    Niboshi A; Ozawa S; Hamaoka K
    Nihon Rinsho; 2008 Feb; 66(2):387-92. PubMed ID: 18265460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of coronary artery dilation and aneurysms in patients with Kawasaki disease based on differential protein expression.
    Liu W; Liu C; Zhang L; Xie X; Gu X; Sang C; Xu M; Xu W; Jia H
    Mol Med Rep; 2018 Feb; 17(2):2402-2414. PubMed ID: 29207079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M1 macrophage is the predominant phenotype in coronary artery lesions following Kawasaki disease.
    Ohashi R; Fukazawa R; Shimizu A; Ogawa S; Ochi M; Nitta T; Itoh Y
    Vasc Med; 2019 Dec; 24(6):484-492. PubMed ID: 31621532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated myeloid dendritic cells accumulate and co-localize with CD3+ T cells in coronary artery lesions in patients with Kawasaki disease.
    Yilmaz A; Rowley A; Schulte DJ; Doherty TM; Schröder NW; Fishbein MC; Kalelkar M; Cicha I; Schubert K; Daniel WG; Garlichs CD; Arditi M
    Exp Mol Pathol; 2007 Aug; 83(1):93-103. PubMed ID: 17335804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipose tissue-derived stem cells suppress coronary arteritis of Kawasaki disease in vivo.
    Uchimura R; Ueda T; Fukazawa R; Hayakawa J; Ohashi R; Nagi-Miura N; Ohno N; Migita M; Itoh Y
    Pediatr Int; 2020 Jan; 62(1):14-21. PubMed ID: 31758839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of innate and adaptive immunity in a murine model of coronary arteritis mimicking Kawasaki disease.
    Schulte DJ; Yilmaz A; Shimada K; Fishbein MC; Lowe EL; Chen S; Wong M; Doherty TM; Lehman T; Crother TR; Sorrentino R; Arditi M
    J Immunol; 2009 Oct; 183(8):5311-8. PubMed ID: 19786535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoprotegerin serum levels in Kawasaki disease: an additional potential marker in predicting children with coronary artery involvement.
    Simonini G; Masi L; Giani T; Piscitelli E; Cimaz R; Vierucci S; Brandi ML; Falcini F
    J Rheumatol; 2005 Nov; 32(11):2233-8. PubMed ID: 16265708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marked acceleration of atherosclerosis after Lactobacillus casei-induced coronary arteritis in a mouse model of Kawasaki disease.
    Chen S; Lee Y; Crother TR; Fishbein M; Zhang W; Yilmaz A; Shimada K; Schulte DJ; Lehman TJ; Shah PK; Arditi M
    Arterioscler Thromb Vasc Biol; 2012 Aug; 32(8):e60-71. PubMed ID: 22628430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience.
    Maric LS; Knezovic I; Papic N; Mise B; Roglic S; Markovinovic L; Tesovic G
    Rheumatol Int; 2015 Jun; 35(6):1053-8. PubMed ID: 25429794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutropenia after intravenous immunoglobulin therapy is associated with coronary artery lesions in children with Kawasaki disease: a case control study.
    Wang Z; Weng F; Li C; Shi H; Tang Z; Qiu H; He Y; Wu R; Chu M
    BMC Pediatr; 2018 Feb; 18(1):76. PubMed ID: 29466965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of anti-apolipoprotein A-2 on an animal model for coronary arteritis in Kawasaki disease.
    Ito F; Oharaseki T; Tsukui D; Kimura Y; Yanagida T; Kishi F; Yamakawa Y; Kameoka Y; Suzuki S; Uno K; Suzuki O; Miura NN; Ohno N; Takahashi K; Kono H; Suzuki K
    Pediatr Rheumatol Online J; 2022 Dec; 20(1):119. PubMed ID: 36550471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kawasaki disease in very young infants: high prevalence of atypical presentation and coronary arteritis.
    Genizi J; Miron D; Spiegel R; Fink D; Horowitz Y
    Clin Pediatr (Phila); 2003 Apr; 42(3):263-7. PubMed ID: 12739925
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathogenesis of Kawasaki disease.
    Takahashi K; Oharaseki T; Yokouchi Y
    Clin Exp Immunol; 2011 May; 164 Suppl 1(Suppl 1):20-2. PubMed ID: 21447126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.